Microtek International

Microtek International Equity

The The Equity of Microtek International (2305.TW) as of Oct 21, 2026 is 2.29 B TWD. In the previous year, The Equity was 2.25 B TWD — a change of 1.64% (higher).

Equity

2.29 BTWD

YoY

1.64%

Last updated:

In 2025, Microtek International's equity was 2.29 B TWD, a 1.64% increase from the 2.25 B TWD equity in the previous year.

The Microtek International Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
2.19 B TWD
Jan 1, 2019
2.15 B TWD
Jan 1, 2020
2.17 B TWD
Jan 1, 2021
2.17 B TWD
Jan 1, 2022
2.18 B TWD
Jan 1, 2023
2.17 B TWD
Jan 1, 2024
2.25 B TWD
Jan 1, 2025
2.29 B TWD
The Microtek International Equity history
YEAREquityYoY
2.29 BTWD+1.64%
2.25 BTWD+3.55%
2.17 BTWD-0.40%
2.18 BTWD+0.40%
2.17 BTWD-0.03%
2.17 BTWD+1.03%
2.15 BTWD-1.87%
2.19 BTWD-2.52%
2.25 BTWD+29.39%
1.74 BTWD-16.68%
2.09 BTWD+47.34%
1.42 BTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Microtek International Stock analysis

What does Microtek International do? Microtek International, Inc. generates revenue through its two primary business segments. The Image Scanners segment designs, manufactures, and sells digital imaging devices for commercial, medical, biotechnical, and industrial applications. The Photoelectron Equipment segment focuses on optical passive devices, optical instrumentations, and other photoelectron equipment. The company's products are sold directly to end-users and through its subsidiaries, which also handle medical equipment sales and technology development consultancy. Revenue streams include direct sales of scanners and photoelectron equipment, as well as consultancy services related to medical technology development. The company serves multiple market segments including commercial, medical, biotechnical, and industrial sectors. Its scanners target businesses requiring high-quality image input and output solutions, while photoelectron equipment caters to industries needing optical instrumentation. Medical equipment sales through subsidiaries support healthcare providers and institutions. The Photoelectron Equipment segment's research and manufacturing activities drive sales of optical passive devices and instrumentation, which are key revenue sources. Microtek's product portfolio includes image scanners for various specialized uses and photoelectron equipment such as optical passive devices and optical instrumentations. These products are marketed under the company's own brand without external branding. The Image Scanners segment's commercial, medical, biotechnical, and industrial scanners are sold directly to customers in those respective sectors, while the Photoelectron Equipment segment's offerings are targeted at industries requiring optical solutions. Subsidiaries handle medical equipment sales and technology consultancy, contributing to overall revenue. Microtek International is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Microtek International's Equity

Microtek International's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Microtek International's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Microtek International's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Microtek International's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Microtek International’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Microtek International stock

The Equity of Microtek International is 2.29 B TWD in 2025.

The Equity of Microtek International changed from 2.25 B TWD to 2.29 B TWD, representing a 1.64% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Microtek International since 2006 – with annual values, charts, and detailed analysis.

The Equity's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Microtek International historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Microtek International

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Microtek International